Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease

University of Calgary

$45,000.00

Mechanisms of neurogenic inflammation and neuronal sensitization in inflammatory bowel disease

FY 2012-13

Summary
Inflammatory Bowel Disease (IBD), including ulcerative colitis and Crohn's disease, affects more than 200,000 Canadians. This chronic disease of the gastrointestinal tract is associated with severe abdominal pain, which in some cases can persist throughout remission phases of the disease. Beyond its economic impact (estimated to more than one billion annually), IBD significantly decrease the quality of life of both patients and their families. Despite recent advances in our understanding of the mechanisms regulating pain sensation, the efficacy of therapeutic approaches in the treatment of chronic pain symptoms remains variable and clinical improvement modest. The research outlined in the present application focuses on understanding the mechanisms involved in nerve sensitization and pain following colonic inflammation. We hypothesize that, by interfering with these processes, we will be able to reduce chronic pain associated with inflammatory conditions such as IBD. We believe that the results from this study could contribute to the development of novel therapeutics for the treatment of chronic pain in IBD patinets.
Program
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
270604
Name
Lapointe Tamia K
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Mechanisms of neurogenic inflammation and neuronal sensitization in inflammatory bowel disease
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
Animal Behavior (Spontaneous Pain); Dextran Sulfate Sodium (Dss)-Induced Colitis; Dorsal Root Ganglion; Immunohistochemistry; Inflammatory And Neurogenic Pain; Inflammatory Bowel Disease; Peripheral And Central Sensitization; Quantitative Pcr; Transient Receptor Vanilloid 1; Visceral Hypersensitivity
Abstract
Inflammatory Bowel Disease (IBD), including ulcerative colitis and Crohn's disease, affects more than 200,000 Canadians. This chronic disease of the gastrointestinal tract is associated with severe abdominal pain, which in some cases can persist throughout remission phases of the disease. Beyond its economic impact (estimated to more than one billion annually), IBD significantly decrease the quality of life of both patients and their families. Despite recent advances in our understanding of the mechanisms regulating pain sensation, the efficacy of therapeutic approaches in the treatment of chronic pain symptoms remains variable and clinical improvement modest. The research outlined in the present application focuses on understanding the mechanisms involved in nerve sensitization and pain following colonic inflammation. We hypothesize that, by interfering with these processes, we will be able to reduce chronic pain associated with inflammatory conditions such as IBD. We believe that the results from this study could contribute to the development of novel therapeutics for the treatment of chronic pain in IBD patinets.
Competitiondate
201210
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Lapointe, Tamia K
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $45,000~ $0~